Lululemon Athletica settled its four-month proxy battle with founder Chip Wilson on terms that hand him two board seats and tacit acknowledgment that $9 billion in market cap erosion since last September demanded governance changes. The agreement, announced hours before the company's annual shareholder meeting threshold, ends Wilson's campaign that began in December when he publicly accused management of strategic drift and called for board reconstitution.
Wilson, who retains a 15.6% stake through his family investment vehicle Hold It All Inc., will see two nominees join Lululemon's board effective immediately. The settlement avoids a formal proxy vote that would have forced the company to air internal strategy disagreements in SEC filings during a quarter when comparable-store sales growth has already decelerated to low single digits. Lululemon's share price closed 22% below its August 2024 peak of $516, with the stock trading at $402 on settlement day—a valuation multiple compression from 28x forward earnings to 21x in seven months.
The fight centers on product execution failures that Wilson flagged in December, specifically citing misjudged fabric weights in women's leggings and delayed rollouts in men's technical categories where Nike and On Running have gained shelf space. Gross margins contracted 110 basis points year-over-year in Q4 2024 to 56.8%, the first sub-57% print since 2020, as markdowns cleared inventory that didn't move at full price. North American revenue growth, which represented 68% of total sales, slowed to 4% in the December quarter compared to 12% growth a year earlier.
Wilson's settlement gives him influence without operational control—a structure that preserves CEO Calvin McDonald's authority while installing oversight he clearly believes was absent. The two board additions bring the total director count to eleven, diluting existing committee voting power and likely forcing strategy reviews on international expansion pacing and the $450M capital expenditure budget allocated for new store formats. One unresolved tension: Wilson has criticized Lululemon's pursuit of footwear as margin-dilutive at a time when the core apparel business needs product innovation, yet the company has already committed to 15 women's running shoe SKUs launching in Q2 2025.
Allocators should track three near-term events. First, Lululemon reports Q1 2025 earnings on June 4, where North American comps will either confirm stabilization or signal deeper brand fatigue. Second, the company's June analyst day will reveal whether Wilson's board presence forces a revision to the $12.5B revenue target for 2026, currently requiring 15% compound annual growth against a 7% run rate. Third, any executive departures in product design or merchandising within 90 days of this settlement would confirm Wilson's influence extended beyond governance into operational personnel.
The settlement closes with Lululemon's market capitalization at $49.2B, still $8.7B below the point where Wilson went public with his concerns. The company now has two quarters to demonstrate the board changes were sufficient, or Wilson's 15.6% stake becomes the fulcrum for a more aggressive intervention when the proxy window reopens in December.